In the future, psychedelics may be used to treat addictions because they can shake up the brain. Along with therapy, ...

In recent years, researchers have expressed renewed optimism that psychedelics can be used in therapeutic settings to help treat addiction and mental illness, intertwined crises that have devastated ...

AUSTIN ― U.S. Marine Cpl. Dakota Meyer, who once rescued three dozen people during a battle in the war-torn mountains of Afghanistan, was still in his 20s when the trauma came for him. Alcoholism, ...

NEW YORK, New York, USA, 10 June 2025 – In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how ...

I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me,” writes Erica Rex, author of the new book “Seeing ...

A group of Texas universities and other institutions have received $50 million from the Texas Health and Human Services Commission to launch a two-year study of ibogaine.

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with effects lasting up to six months.

A secondary analysis of the KARE trial found that ketamine’s psychoactive experiences did not predict alcohol abstinence in ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...